Publication
Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1
Journal Paper/Review - Jul 1, 2013
Stickel Felix, Worni Mathias, Pache Isabelle, Moradpour Darius, Helbling Beat, Borovicka Jan, Gerlach Tilman J
Units
PubMed
Doi
Citation
Stickel F, Worni M, Pache I, Moradpour D, Helbling B, Borovicka J, Gerlach T. Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1. Am J Gastroenterol 2013; 108:1176-8.
Type
Journal Paper/Review (English)
Journal
Am J Gastroenterol 2013; 108
Publication Date
Jul 1, 2013
Issn Electronic
1572-0241
Pages
1176-8